We are pleased to draw your attention to the following ‘Eli Lilly (Suisse) owned content’.
Thank You for Your Participation!
If you missed the session, don’t worry! We’re planning other live streams in the future.
Disclaimers
Some of the substances/blood biomarkers shown in this email and discussed in this webinar are studied in clinical trials and have not obtained market authorization in Switzerland.
Healthcare professionals can request the references from the company at any time.
Agenda
Welcome & Introduction
5 min
5 Ironmans Beat Alzheimer’s
Mr. Hassan Fadli (Switzerland) – Founder of 5 Ironmans Beat Alzheimer’s, Alzheimer’s Advocate – 10 min
Overcoming Barriers to an Earlier Diagnosis
Prof. Sebastiaan Engelborghs (Belgium) – Professor and Chairman of Neurology and Neurosciences at Vrije Universiteit Brussel and UZ Brussel – 10 min
Earlier Diagnosis: A Turning Point for Action
Dr. Juan Fortea (Spain) – Neurologist and Director of the Memory Unit of the Neurology Department,Hospital de la Santa Creu i Sant Pau, Barcelona, Spain – 10 min
From Awareness to Action
Dr. Jane Mahakian (USA) – Gerontologist and Founder of Alzheimer’s Care Armenia– 10 min
Q&A Session
All – 15 min
Ask a Question
By participating in our discussion in this chat, you consent to the processing of your personal data by medizinonline.com solely for the purpose of facilitating this conversation. Your information will be handled in accordance with medizinonline.com’s Privacy Policy and will not be disclosed to third parties.
Eli Lilly (Suisse) SA, Chemin des Coquelicots 16, P.O. 580, CH-1214 Vernier
All rights reserved.
PP-AD-CH-0262/09.2025
We are pleased to draw your attention to the following ‘Eli Lilly (Suisse) owned content’.
Ask a Question
By participating in our discussion in this chat, you consent to the processing of your personal data by medizinonline.com solely for the purpose of facilitating this conversation. Your information will be handled in accordance with medizinonline.com’s Privacy Policy and will not be disclosed to third parties.